Home › Astrocytoma
Pag-aaral pangklinika para sa Astrocytoma na nagre-recruit sa U.S.
47 pag-aaral para sa Astrocytoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX15 pag-aaral
- Boston, MA13 pag-aaral
- New York City, NY10 pag-aaral
- Chicago, IL9 pag-aaral
- Seattle, WA7 pag-aaral
- Philadelphia, PA7 pag-aaral
- Miami, FL7 pag-aaral
- Durham, NC7 pag-aaral
- San Francisco, CA6 pag-aaral
- Columbus, OH6 pag-aaral
- Aurora, CO6 pag-aaral
- Washington, DC5 pag-aaral
- Cincinnati, OH5 pag-aaral
- Salt Lake City, UT5 pag-aaral
- Los Angeles, CA4 pag-aaral
- St. Louis, MO4 pag-aaral
- Baldwin Park, CA4 pag-aaral
- Rochester, MN3 pag-aaral
- Queens, NY3 pag-aaral
- Edison, NJ3 pag-aaral
- San Antonio, TX3 pag-aaral
- Richmond, VA3 pag-aaral
- Nashville, TN3 pag-aaral
- Dallas, TX3 pag-aaral
- Detroit, MI3 pag-aaral
- Cleveland, OH3 pag-aaral
- Lexington, KY3 pag-aaral
- New Haven, CT3 pag-aaral
- Kansas City, KS3 pag-aaral
- Pittsburgh, PA3 pag-aaral
- Birmingham, AL3 pag-aaral
- Madison, WI3 pag-aaral
- Ann Arbor, MI3 pag-aaral
Ayos sa estado
- Alabama3 pag-aaral
- California10 pag-aaral
- Colorado7 pag-aaral
- Connecticut3 pag-aaral
- District of Columbia4 pag-aaral
- Florida9 pag-aaral
- Georgia3 pag-aaral
- Illinois9 pag-aaral
- Kansas3 pag-aaral
- Kentucky4 pag-aaral
- Massachusetts13 pag-aaral
- Michigan6 pag-aaral
- Minnesota5 pag-aaral
- Missouri4 pag-aaral
- New Jersey4 pag-aaral
- New York10 pag-aaral
- North Carolina8 pag-aaral
- Ohio9 pag-aaral
- Pennsylvania8 pag-aaral
- Tennessee4 pag-aaral
- Texas16 pag-aaral
- Utah5 pag-aaral
- Virginia5 pag-aaral
- Washington8 pag-aaral
- Wisconsin3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Observational Connectomics in Adults Undergoing Resection of WHO II-IV Glioma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07927595Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07628647Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07215910GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07301268A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05765812Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07544992Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06815029Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06860594Implantable Microdevice In Primary Brain Tumors
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT04135807SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT05303519Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT06344130Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07439172Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05417594MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
Nagre-recruitPhase 2
Edad 18 hanggang 98 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07831369A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Nagre-recruitPhase 1
Edad 19 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05698524SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Nagre-recruitPhase 1/2
Edad 2 hanggang 24 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04923126FearLess in NeuroOncology
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06989086Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Nagre-recruitPhase 1
36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388Serial MRI Scans During Radiation Therapy
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04188535Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07733674Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT04623931Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.